Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Antonia J. Lewis
Observed names:
Antonia Lewis,
Lewis, Antonia J.
Institution:
GlaxoSmithKline (United Kingdom)
Observed institutions:
GlaxoSmithKline (United Kingdom),
GlaxoSmithKline (France),
GlaxoSmithKline Research & Development Limited (United Kingdom)
OpenAlex ID:
A5113531428
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
2013
·
Olivier Mirguet
, Romain Gosmini
, et al.
·
Journal of Medicinal Chemistry
·
336
The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor
2014
·
Romain Gosmini
, Van Loc Nguyen
, et al.
·
Journal of Medicinal Chemistry
·
201
Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides
2012
·
Paul Bamborough
, Hawa Diallo
, et al.
·
Journal of Medicinal Chemistry
·
187
Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs
2021
·
Robert P. Law
, Joao Nunes
, et al.
·
Angewandte Chemie International Edition
·
126
Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening
2020
·
Christopher R. Wellaway
, Dominique Amans
, et al.
·
Journal of Medicinal Chemistry
·
75
Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype
2020
·
Christopher R. Wellaway
, Paul Bamborough
, et al.
·
Journal of Medicinal Chemistry
·
59
Discovery of a Novel Bromodomain and Extra Terminal Domain (BET) Protein Inhibitor, I-BET282E, Suitable for Clinical Progression
2021
·
Katherine L. Jones
, Dominic M. Beaumont
, et al.
·
Journal of Medicinal Chemistry
·
45
Naphthyridines as Novel BET Family Bromodomain Inhibitors
2013
·
Olivier Mirguet
, Yann Lamotte
, et al.
·
ChemMedChem
·
39
GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family
2020
·
Alex Preston
, Stephen J. Atkinson
, et al.
·
ACS Medicinal Chemistry Letters
·
34
Identification of a Series of N -Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal Domain (BET) Proteins
2021
·
Lee A. Harrison
, Stephen J. Atkinson
, et al.
·
Journal of Medicinal Chemistry
·
31
Cellular Target Engagement Approaches to Monitor Epigenetic Reader Domain Interactions
2019
·
Alexander N. Phillipou
, Charles S. Lay
, et al.
·
SLAS DISCOVERY
·
14
PDF
Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs
2021
·
Robert P. Law
, Joao Nunes
, et al.
·
Angewandte Chemie
·
6
Abstract 4854: Alleviation of low pH induced immunosuppression through antagonism of the pH sensor GPR65 in highly glycolytic NSCLC tumors
2025
·
Prajna Behera
, Samantha Buongervino
, et al.
·
Cancer Research
·
2
Show more works
View as search
Works count:
15
Citation count:
1,155
H-index:
11
I10-index:
11
Year
Topic
Type